Keipert, Susanne http://orcid.org/0000-0002-6618-7379
Lutter, Dominik http://orcid.org/0000-0002-8800-0683
Schroeder, Bjoern O. http://orcid.org/0000-0002-6716-8284
Brandt, Daniel
Ståhlman, Marcus
Schwarzmayr, Thomas
Graf, Elisabeth
Fuchs, Helmut http://orcid.org/0000-0002-5143-2677
de Angelis, Martin Hrabe http://orcid.org/0000-0002-7898-2353
Tschöp, Matthias H. http://orcid.org/0000-0002-4744-371X
Rozman, Jan http://orcid.org/0000-0002-8035-8904
Jastroch, Martin
Article History
Received: 14 March 2019
Accepted: 10 December 2019
First Online: 31 January 2020
Change Date: 16 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-22119-x
Competing interests
: M.H.T. serves as SAB member for Novo Nordisk and ERX Pharmaceuticals Inc. All other authors declare no competing interests.